{"chunk_id": "_Drugs-in-Pregnancy-and-Lactation--Improved-Benefit-Risk-Information_-January-22--2015-Issue__chunk_2", "source": "_Drugs-in-Pregnancy-and-Lactation--Improved-Benefit-Risk-Information_-January-22--2015-Issue", "text": "ders to determine whether or not to use a particular \nproduct and how best to use it safely. This is especially important during pregnancy or lactation.  In \nDecember, FDA pub lished the Content and Format of Labeling for Human Prescription Drug and \nBiological Products; Requirements for Pregnancy and Lactation Labeling , referred to as the \n“Pregnancy and Lactation Labeling Rule” (PLLR). This rule sets standards for how information about \nusing medicines during pregnancy and breastfeeding is pr"}